Article Details
Retrieved on: 2025-09-01 18:58:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company's lead product candidate is a monoclonal antibody targeting the CTLA-4 immune checkpoint, aiming to enhance the body's immune response ...
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here